And then, we found that the oral administration of 12-KLCA, a derivate of LCA that is very little in SUCs and their recipient mice, could exert an anti-inflammatory effect on experimental colitis through the inhibition of IL-17A secreted by ILC3s. The gene discussed is IL17A; the disease is colitis.